Martínez-Sanz, P.; Hoogendijk, A.J.; Verkuijlen, P.J.J.H.; Schornagel, K.; van Bruggen, R.; van den Berg, T.K.; Tytgat, G.A.M.; Franke, K.; Kuijpers, T.W.; Matlung, H.L.
CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells. Cancers 2021, 13, 4261.
https://doi.org/10.3390/cancers13174261
AMA Style
Martínez-Sanz P, Hoogendijk AJ, Verkuijlen PJJH, Schornagel K, van Bruggen R, van den Berg TK, Tytgat GAM, Franke K, Kuijpers TW, Matlung HL.
CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells. Cancers. 2021; 13(17):4261.
https://doi.org/10.3390/cancers13174261
Chicago/Turabian Style
Martínez-Sanz, Paula, Arjan J. Hoogendijk, Paul J. J. H. Verkuijlen, Karin Schornagel, Robin van Bruggen, Timo K. van den Berg, Godelieve A. M. Tytgat, Katka Franke, Taco W. Kuijpers, and Hanke L. Matlung.
2021. "CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells" Cancers 13, no. 17: 4261.
https://doi.org/10.3390/cancers13174261
APA Style
Martínez-Sanz, P., Hoogendijk, A. J., Verkuijlen, P. J. J. H., Schornagel, K., van Bruggen, R., van den Berg, T. K., Tytgat, G. A. M., Franke, K., Kuijpers, T. W., & Matlung, H. L.
(2021). CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells. Cancers, 13(17), 4261.
https://doi.org/10.3390/cancers13174261